Ethical Consideration in Preclinical Trials Preclinical trials are essential for evaluating the safety and effectiveness of new drugs and treatments before they are tested on humans. While these studies play a vital role in advancing medical research, they also involve ethical challenges that must be carefully navigated to ensure responsible and humane practices. Upholding Animal […]
Ethical Considerations in Preclinical Trials Read More »
Greetings from Trials360! As we reflect on our anniversary and the past year, we are filled with gratitude and pride in the remarkable strides we have made together. Despite the challenges we faced, our team at Trials360 has achieved significant milestones that have further solidified our position as a leader in the pre-clinical and clinical
Greetings from Trials360 Read More »
Preclinical Research: The Foundation of Successful Drug Development Preclinical research is the cornerstone of drug development, providing essential insights before a drug reaches human trials. It is the stage where safety, efficacy, and the biological behavior of drug candidates are rigorously tested, laying the groundwork for success in later phases. Contract Research Organizations (CROs) play
Preclinical Research: The Foundation of Successful Drug Development Read More »
Exciting news has emerged in the field of cystic fibrosis treatment, with the development of a promising new therapy that could revolutionize patient care. Cystic fibrosis (CF) is a rare genetic disease that affects the lungs …
New Advancements in Cystic Fibrosis Treatment Read More »
Animal Model Development for Chronic Inflammation Chronic inflammation (CI), characterized by unresolved inflammation persisting for prolonged periods, can exacerbate tissue damage in various organs. Understanding the cellular and intracellular pathways involved in CI is crucial for developing effective treatments. Animal models play a significant role in studying CI mechanisms and in developing new therapies for
Animal Model Development for Chronic Inflammation Read More »
Trials360 Achieves Milestone in Phase 2b Clinical Trial for Acute Stroke Patients Acute stroke and intracerebral hemorrhages represent some of the most common admissions in neurological intensive care units. Effective management of these conditions is crucial for achieving better patient outcomes and alleviating the substantial burden on families and society. One critical aspect of this
Trials360 Achieves Milestone in Phase 2b Clinical Trial for Acute Stroke Patients Read More »
Clinical Trials Diversity and Inclusion • Why Diversity and Inclusion in Clinical Trials Matter Clinical trials are the cornerstone of medical advancements, driving innovation and improving patient care. However, historically, these trials have often lacked diversity, with underrepresentation of certain demographics such as racial and ethnic minorities, women, the elderly, and those with disabilities. Based
Clinical Trials Diversity and Inclusion Read More »
Trials360 Developed Stroke Rat Model Description: Greetings from the Trials 360 monthly newsletter! We are thrilled to announce another milestone at Trials 360: The successful development of a Stroke Rat Model through Common Carotid Artery Occlusion (CCAO). This achievement holds significant importance in medical research, particularly in the study of Ischemic Stroke, a major global
Trials360 Developed Stroke Rat Model Read More »
Trials360 Developed ALI Rat Model Description: Trials 360 is excited to announce the development of an in-house Acute Lung Injury (ALI) rat model for studying pulmonary diseases. The model’s validation tests included X-ray, CBC (Complete Blood Count), ESR (Erythrocyte Sedimentation Rate), ELISA-IL 6, Wet & Dry weigh, and histopathology. This model provides a robust platform
Trials360 Developed ALI Rat Model Read More »
